16-06-2020
Jer123 / Shutterstock.com
The US Patent and Trademark Office (USPTO) has waived fees for trademarks covering COVID-19 medical products and services.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
USPTO, COVID-19, coronavirus, FDA, trademark, fees, waiver, deadline, extension, funding, Andrei Iancu
USTPO unveils new fast-track pilot for patent appeals
02-07-2020
USPTO extends fee deadlines but warns relief will end soon
30-06-2020
US launches new copyright rules for social media and blogs
23-06-2020
UKIPO brings ‘interrupted days’ to an end
23-06-2020
USPTO waives filing and fee deadlines amid pandemic
01-04-2020
US $2tn coronavirus bill grants USPTO emergency powers
27-03-2020
